Pacira BioSciences comments on ruling on Exparel patent litigation from U.S. District Court for the District of New Jersey
Pacira BioSciences, Inc announced that the U.S. District Court for the District of New Jersey has found that the company’s U.S. Patent No. 11,033,495 (the ‘495 patent) is… read more.
